Trials / Completed
CompletedNCT03980561
UH3 Varenicline for Cannabis Use Disorder
Varenicline for the Treatment of DSM 5 Cannabis Use Disorder in Adults
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Marijuana is the most commonly used illicit drug. There is high demand for effective interventions for cannabis use disorder, yet few specific treatments for have been developed. This study will evaluate the efficacy of varenicline for reducing marijuana use in people who use marijuana frequently.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline | Active medication |
| DRUG | Placebo | Inactive medication |
Timeline
- Start date
- 2020-01-31
- Primary completion
- 2023-02-09
- Completion
- 2023-12-01
- First posted
- 2019-06-10
- Last updated
- 2024-01-18
- Results posted
- 2024-01-18
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03980561. Inclusion in this directory is not an endorsement.